Financial results - DIATEST BIOSANO-MED SRL

Financial Summary - Diatest Biosano-Med Srl
Unique identification code: 29374089
Registration number: J03/1575/2011
Nace: 8622
Sales - Ron
57.552
Net Profit - Ron
26.135
Employees
1
Open Account
Company Diatest Biosano-Med Srl with Fiscal Code 29374089 recorded a turnover of 2024 of 57.552, with a net profit of 26.135 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Diatest Biosano-Med Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 0 0 0 0 0 0 4.658 41.357 57.552
Total Income - EUR 0 0 0 0 0 0 0 4.658 41.357 57.552
Total Expenses - EUR 0 901 886 870 853 837 818 1.669 16.670 29.691
Gross Profit/Loss - EUR 0 -901 -886 -870 -853 -837 -818 2.990 24.688 27.861
Net Profit/Loss - EUR 0 -901 -886 -870 -853 -837 -818 2.244 24.274 26.135
Employees 0 0 0 0 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 39.9%, from 41.357 euro in the year 2023, to 57.552 euro in 2024. The Net Profit increased by 1.996 euro, from 24.274 euro in 2023, to 26.135 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Diatest Biosano-Med Srl

Rating financiar

Financial Rating -
DIATEST BIOSANO-MED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Diatest Biosano-Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Diatest Biosano-Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Diatest Biosano-Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Diatest Biosano-Med Srl - CUI 29374089

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 171 168 165 162 159 155 0 0 62.627
Current Assets 45 265 260 256 251 246 240 3.563 27.722 15.576
Inventories 0 145 142 140 137 134 131 0 0 0
Receivables 0 0 0 0 0 0 0 44 26.132 1.185
Cash 45 120 118 116 114 111 109 3.519 1.590 14.391
Shareholders Funds 45 -857 -842 -827 -811 -795 -778 2.285 26.552 52.538
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 0 1.293 1.271 1.247 1.223 1.200 1.173 1.278 1.170 25.666
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 15.576 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.185 euro and cash availability of 14.391 euro.
The company's Equity was valued at 52.538 euro, while total Liabilities amounted to 25.666 euro. Equity increased by 26.135 euro, from 26.552 euro in 2023, to 52.538 in 2024.

Risk Reports Prices

Reviews - Diatest Biosano-Med Srl

Comments - Diatest Biosano-Med Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.